Join Dr. David S. Filippi as he explores the cutting-edge science of GLP-1 agonists—medications originally designed for diabetes but now revolutionizing weight management. From the intricate brain pathways that regulate hunger to the real-world health impacts of obesity, discover why GLP-1 agonists like semaglutide and tirzepatide are being hailed as game-changers. Visit significant-podcast.com for more insights and episodes.

Ver todos los episodios